Sanofi Pasteur, Inc.
163Patents
123Active
163Granted
54Portfolio score
Filing activity: Aug 4, 1994 → Mar 4, 2024 · 52 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8790658B2 | Antigen-adjuvant compositions and methods | Human Necessities | 1,002 | Active |
| US7098023B1 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Chemistry; Metallurgy | 35 | Expired |
| US7074914B1 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 31 | Expired |
| US7122368B1 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Chemistry; Metallurgy | 30 | Expired |
| US7129339B1 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Chemistry; Metallurgy | 29 | Expired |
| US7135560B1 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Chemistry; Metallurgy | 29 | Expired |
| US7081530B1 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Chemistry; Metallurgy | 28 | Expired |
| US7442523B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 26 | Expired |
| US9670506B2 | Modified immunization vectors | Emerging Cross-Sectional Technologies | 18 | Active |
| US7388090B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 18 | Active |
| US7396532B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 17 | Active |
| US7404958B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 17 | Active |
| US7390493B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 17 | Active |
| US7385047B1 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 17 | Active |
| US7405291B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 17 | Active |
| US7786278B2 | Modified CEA nucleic acid and expression vectors | Chemistry; Metallurgy | 16 | Active |
| US8017590B1 | Method of inducing and/or enhancing an immune response to tumor antigens | Chemistry; Metallurgy | 15 | Expired |
| US7671186B2 | Chimeric immunogens | Physics | 14 | Active |
| US7378258B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 14 | Expired |
| US7081245B2 | Chlamydia antigens and corresponding DNA fragments and uses thereof | Chemistry; Metallurgy | 13 | Expired |
| US8207314B2 | Tumor antigens for prevention and/or treatment of cancer | Human Necessities | 13 | Active |
| US7019125B2 | Chlamydia antigens and corresponding DNA fragments and uses thereof | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7834166B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 12 | Active |
| US7338786B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | Human Necessities | 11 | Expired |
| US7070792B2 | Chlamydia antigens and corresponding DNA fragments and uses thereof | Emerging Cross-Sectional Technologies | 11 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.